Darling EVP exercises 5,760 options, sells DAR shares

Darling Ingredients EVP, General Counsel & Secretary Nicholas James Kemphaus reported multiple equity transactions in the company’s stock.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Darling Ingredients EVP, General Counsel & Secretary Nicholas James Kemphaus reported multiple equity transactions in the company’s stock. On February 13, 2026, he exercised 5,760 stock options at an exercise price of $12.29 per share, receiving an equal number of Darling Ingredients common shares.

On the same date, he used 3,099 shares of common stock at $52.03 per share to cover the option exercise price or related tax obligations. He then executed open-market sales of common stock in several tranches: 2,661 shares at $52.03, 2,546 shares at $52.29, 620 shares at $51.96, and 3 shares at $52.56 per share. After these transactions, he directly owned 33,876 shares of Darling Ingredients common stock.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 7 txns

Insider Kemphaus Nicholas James

Role EVP Gen. Counsel & Secretary

Sold 5,830 shs ($304K)

Approx. gross sale proceeds $304K

Approx. exercise cost $71K

Type	Security	Shares	Price	Value
Exercise	Options (right to buy)	5,760	$0.00	$0.00
Exercise	Common Stock	5,760	$12.29	$71K
Exercise Price or Tax Liability	Common Stock	3,099	$52.03	$161K
Sale	Common Stock	2,661	$52.03	$138K
Sale	Common Stock	2,546	$52.29	$133K
Sale	Common Stock	620	$51.96	$32K
Sale	Common Stock	3	$52.56	$157.68

Holdings After Transaction: Options (right to buy) — 0 contracts (Direct); Common Stock — 33,876 shares (Direct)

Footnotes (1)

F1. Options granted pursuant to 2017 Omnibus Incentive Plan to purchase 1,920 shares became exercisable on 02/06/2018, 02/06/2019 and 02/06/2020.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did DAR EVP Nicholas Kemphaus report on this Form 4?

Nicholas James Kemphaus reported exercising 5,760 stock options and receiving the same number of Darling Ingredients common shares. He then used 3,099 shares to cover tax or exercise costs and sold additional shares in several open-market transactions on February 13, 2026.

How many Darling Ingredients (DAR) stock options did Nicholas Kemphaus exercise?

He exercised 5,760 options at an exercise price of $12.29 per share, converting them into 5,760 shares of Darling Ingredients common stock. These options were granted under the company’s 2017 Omnibus Incentive Plan and had become exercisable in prior years.

How many Darling Ingredients (DAR) shares did Nicholas Kemphaus sell, and at what prices?

He sold common stock in several tranches: 2,661 shares at $52.03, 2,546 shares at $52.29, 620 shares at $51.96, and 3 shares at $52.56 per share. These were reported as open-market or private sale transactions on February 13, 2026.

What does the tax-withholding transaction mean in the DAR Form 4 for Nicholas Kemphaus?

The filing shows a code F transaction where 3,099 common shares at $52.03 were used to pay the option exercise price or related tax liability. This is a non-open-market disposition commonly used to satisfy obligations without paying cash.

How many Darling Ingredients (DAR) shares does Nicholas Kemphaus own after these transactions?

Following the reported exercise, tax-withholding disposition, and sales, Nicholas James Kemphaus directly holds 33,876 shares of Darling Ingredients common stock. This figure reflects his ownership after all Form 4 transactions dated February 13, 2026.

What is Nicholas Kemphaus’s role at Darling Ingredients (DAR) in this Form 4?

The Form 4 identifies Nicholas James Kemphaus as an officer of Darling Ingredients, serving as Executive Vice President, General Counsel & Secretary. The transactions reported reflect his personal direct ownership in the company’s common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/17/2026 - 04:20 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kemphaus Nicholas James

(Last)

(First)

(Middle)

5601 N. MACARTHUR BLVD.

(Street)

IRVING

75038

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
DARLING INGREDIENTS INC. [ DAR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP Gen. Counsel & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/13/2026		M		5,760	A	$12.29	42,805	D
Common Stock	02/13/2026		F		3,099	D	$52.03	39,706	D
Common Stock	02/13/2026		S		2,661	D	$52.03	37,045	D
Common Stock	02/13/2026		S		2,546	D	$52.29	34,499	D
Common Stock	02/13/2026		S		620	D	$51.96	33,879	D
Common Stock	02/13/2026		S		3	D	$52.56	33,876	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options (right to buy)	$12.29	02/13/2026		M			5,760	⁽¹⁾	02/06/2027	Common Stock	5,760	$0	0	D

Explanation of Responses:

1. Options granted pursuant to 2017 Omnibus Incentive Plan to purchase 1,920 shares became exercisable on 02/06/2018, 02/06/2019 and 02/06/2020.

	/s/ Teun Tchornobay, as Attorney-in-Fact for Nick Kemphaus	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR